Description
The report assesses the market dynamics, economic and public health potential, key barriers, and technical assistance pathways for localizing health product and medical technology manufacturing across Africa to inform pharmaceutical manufacturers, investors, and regional health policymakers. The study highlights Manufacturing Africa’s portfolio of 21 supported health manufacturers, which has secured ~£600 million in foreign direct investments, and identifies critical opportunities across pooled procurement mechanisms, regulatory harmonization, and technology transfers for local vaccine and active pharmaceutical ingredient (API) production.
